Last reviewed · How we verify
Postop oral oxycodone & acetaminophen — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Postop oral oxycodone & acetaminophen (Postop oral oxycodone & acetaminophen) — AdventHealth.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Postop oral oxycodone & acetaminophen TARGET | Postop oral oxycodone & acetaminophen | AdventHealth | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Postop oral oxycodone & acetaminophen CI watch — RSS
- Postop oral oxycodone & acetaminophen CI watch — Atom
- Postop oral oxycodone & acetaminophen CI watch — JSON
- Postop oral oxycodone & acetaminophen alone — RSS
Cite this brief
Drug Landscape (2026). Postop oral oxycodone & acetaminophen — Competitive Intelligence Brief. https://druglandscape.com/ci/postop-oral-oxycodone-acetaminophen. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing